JP2024541680A5 - - Google Patents
Info
- Publication number
- JP2024541680A5 JP2024541680A5 JP2024533211A JP2024533211A JP2024541680A5 JP 2024541680 A5 JP2024541680 A5 JP 2024541680A5 JP 2024533211 A JP2024533211 A JP 2024533211A JP 2024533211 A JP2024533211 A JP 2024533211A JP 2024541680 A5 JP2024541680 A5 JP 2024541680A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- sequence
- nos
- antigen
- binding unit
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNPCT/CN2021/134930 | 2021-12-02 | ||
| CN2021134930 | 2021-12-02 | ||
| PCT/CN2022/136276 WO2023098888A1 (en) | 2021-12-02 | 2022-12-02 | Ccr8 antigen binding unit and uses thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024541680A JP2024541680A (ja) | 2024-11-08 |
| JP2024541680A5 true JP2024541680A5 (https=) | 2025-12-05 |
Family
ID=86611552
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024533211A Pending JP2024541680A (ja) | 2021-12-02 | 2022-12-02 | Ｃｃｒ８抗原結合ユニット及びその使用 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20250034266A1 (https=) |
| EP (1) | EP4441098A4 (https=) |
| JP (1) | JP2024541680A (https=) |
| KR (1) | KR20240112929A (https=) |
| CN (1) | CN119072494A (https=) |
| AU (1) | AU2022400921A1 (https=) |
| CA (1) | CA3239784A1 (https=) |
| IL (1) | IL313177A (https=) |
| MX (1) | MX2024006743A (https=) |
| TW (1) | TW202342533A (https=) |
| WO (1) | WO2023098888A1 (https=) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4661869A1 (en) | 2023-02-06 | 2025-12-17 | Bayer Aktiengesellschaft | Combinations of dgk (diacylglycerol kinase) inhibitors and immune checkpoint inhibitors and modulators |
| WO2024240224A1 (zh) * | 2023-05-23 | 2024-11-28 | 再鼎医药(上海)有限公司 | 包含抗ccr8抗体的制剂及其用途 |
| JPWO2024248037A1 (https=) | 2023-05-30 | 2024-12-05 | ||
| TW202540200A (zh) | 2023-12-01 | 2025-10-16 | 美商基利科學股份有限公司 | 抗ｆａｐ－ｌｉｇｈｔ融合蛋白及其用途 |
| WO2025145207A1 (en) | 2023-12-29 | 2025-07-03 | Bristol-Myers Squibb Company | Combination therapy of kras inhibitor and treg-depleting agent |
| CN120230205A (zh) * | 2023-12-29 | 2025-07-01 | 苏州泽璟生物制药股份有限公司 | 包含ccr8抗原结合结构域的多特异性抗体 |
| WO2025186043A1 (en) | 2024-03-06 | 2025-09-12 | Bayer Aktiengesellschaft | Pharmaceutical formulation for anti-ccr8 antibodies |
| WO2025259871A1 (en) | 2024-06-14 | 2025-12-18 | Gilead Sciences, Inc. | Anti-ccr8 antibodies and uses thereof |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2007044756A2 (en) * | 2005-10-11 | 2007-04-19 | Icos Corporation | Monoclonal antibodies recognizing human ccr8 |
| US10087259B1 (en) * | 2014-04-28 | 2018-10-02 | Memorial Sloan Kettering Cancer Center | Depleting tumor-specific tregs |
| CN110835371A (zh) * | 2018-08-19 | 2020-02-25 | 普米斯生物技术(苏州)有限公司 | 抗ccr8单克隆抗体及其应用 |
| WO2020138489A1 (ja) * | 2018-12-27 | 2020-07-02 | 塩野義製薬株式会社 | 新規抗ｃｃｒ８抗体 |
| TWI890283B (zh) * | 2020-02-14 | 2025-07-11 | 美商基利科學股份有限公司 | 結合ccr8之抗體及融合蛋白及其用途 |
| AU2021244200A1 (en) * | 2020-03-23 | 2022-11-24 | Bristol-Myers Squibb Company | Anti-CCR8 antibodies for treating cancer |
| TW202216771A (zh) * | 2020-06-26 | 2022-05-01 | 德商拜耳廠股份有限公司 | 用於治療應用之ccr8抗體 |
-
2022
- 2022-12-02 US US18/715,739 patent/US20250034266A1/en active Pending
- 2022-12-02 CA CA3239784A patent/CA3239784A1/en active Pending
- 2022-12-02 KR KR1020247021902A patent/KR20240112929A/ko active Pending
- 2022-12-02 WO PCT/CN2022/136276 patent/WO2023098888A1/en not_active Ceased
- 2022-12-02 CN CN202280080188.8A patent/CN119072494A/zh active Pending
- 2022-12-02 IL IL313177A patent/IL313177A/en unknown
- 2022-12-02 AU AU2022400921A patent/AU2022400921A1/en active Pending
- 2022-12-02 MX MX2024006743A patent/MX2024006743A/es unknown
- 2022-12-02 TW TW111146368A patent/TW202342533A/zh unknown
- 2022-12-02 EP EP22900692.9A patent/EP4441098A4/en active Pending
- 2022-12-02 JP JP2024533211A patent/JP2024541680A/ja active Pending